Immunethep is a biotech startup company that is developing anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. We are working on preventing and treating infectious diseases to improve global health (SDG#3) for a safer tomorrow free of AntiMicrobial Resistance (AMR). We will accomplish our mission by developing anti-infective immunotherapies that potentiate a natural and strong immune response from the infected host, reducing the disease burden and mortality rates.
Looking for a particular IMMUNETHEP employee's phone or email?
The IMMUNETHEP annual revenue was $6 million in 2026.
Pedro Madureira is the Co-founder and CSO of IMMUNETHEP.
13 people are employed at IMMUNETHEP.
IMMUNETHEP is based in Cantanhede, Coimbra.
The NAICS codes for IMMUNETHEP are [541713, 541, 5417, 54171, 54].
The SIC codes for IMMUNETHEP are [87, 873].